Treatment success with pulsed field ablation was higher at 1 year than with antiarrhythmic drug therapy for patients with persistent atrial fibrillation.

CellFX marks another route for Afib ablation technology ...

A novel pulsed field ablation technology was safe and prevented atrial arrhythmia recurrence in most patients with paroxysmal ...

Guidelines recommend a trial of antiarrhythmic drugs before catheter ablation for persistent atrial fibrillation. Whether pulsed field ablation (PFA) may be a preferred initial treatment is ...

London, United Kingdom – 2 September 2024: A catheter ablation procedure widely used to treat the most common heart rhythm disorder significantly reduces the burden of atrial fibrillation (AF) and ...

In seven patients, there were no signs of toxicity with proton-beam radioablation, clearing the way for future studies.

In patients with persistent atrial fibrillation, those receiving pulsed field ablation as first-line therapy had less risk ...

In the single-arm FULCRUM-VT trial, 59% of patients remained free of recurrent VT at 6 months, with less amiodarone use.

The first US safety and efficacy study of radiofrequency (RF) catheter ablation for vagal denervation in patients with neurocardiogenic syncope suggests the procedure can correct autonomic bradycardia ...